Results of rat Pig-a/PIGRET assay with a single dose regimen of 1,3-propane sultone and 2-acetyl aminofluorene

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 811, Issue , 2016, Pages 75-79

  Shigano, Miyuki ^a   Ishii, Nana ^a   Takashima, Rie ^b   Harada, Hideki ^a   Takasawa, Hironao ^a   Hamada, Shuichi ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

^b Tsukubamirai shi   (Japan)

Author keywords

1,3 propane sultone; 2 acetyl aminofluorene; In vivo mutation assay; PIGRET assay; RBC Pig a assay

Indexed keywords

N (2 FLUORENYL)ACETAMIDE; PROPANESULTONE; 1,3-PROPANE SULTONE; MEMBRANE PROTEIN; MUTAGENIC AGENT; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL ASSAY; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; GENOTOXICITY; GENOTOXICITY ASSAY; MALE; NONHUMAN; PIG A ASSAY; PIGRET ASSAY; PRIORITY JOURNAL; RAT; RETICULOCYTE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; MUTAGEN TESTING; PROCEDURES; SPRAGUE DAWLEY RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MALE; MEMBRANE PROTEINS; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY; RETICULOCYTES; THIOPHENES;

EID: 84963569129     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2016.04.001     Document Type: Article

References (21)

1. [1] Bryce, S.M., Bemis, J.C., Dertinger, S.D., In vivo mutation assay based on the endogenous Pig-a locus. Environ. Mol. Mutagen. 49 (2008), 256–264.
2. [2] Phonethepswath, S., Bryce, S.M., Bemis, J.C., Dertinger, S.D., Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. Mutat. Res. 657 (2008), 122–126.
3. [3] Miura, D., Dobrovolsky, V.N., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ. Mol. Mutagen. 49 (2008), 614–621.
4. [4] Miura, D., Dobrovolsky, V.N., Mittelstaedt, R.A., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ. Mol. Mutagen. 49 (2008), 622–630.
5. [5] Schuler, M., Gollapudi, B.B., Thybaud, V., Kim, J.H., Need and potential value of the Pig-a in vivo mutation assay—a HESI perspective. Environ. Mol. Mutagen. 52 (2011), 685–689.
6. [6] Gollapudi, B.B., Lynch, A.M., Heflich, R.H., Dertinger, S.D., Dobrovolsky, V.N., Froetschl, R., Horibata, K., Kenyon, M.O., Kimoto, T., Lovell, D.P., Stankowski, L.F. Jr., White, P.A., Witt, K.L., Tanir, J.Y., The in vivo Pig-a assay: a report of the international workshop on genotoxicity testing (IWGT) workgroup. Mutat. Res. 783 (2015), 23–35.
7. [7] Low, M.G., The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim. Biophys. Acta. 988 (1989), 427–454.
8. [8] Cross, G.A.M., Glycolipid anchoring of plasma membrane proteins. Annu. Rev. Cell Biol. 6 (1990), 1–39.
9. [9] Kimoto, T., Chikura, S., Suzuki, K., Kobayashi, X.-M., Itano, Y., Horibata, K., Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ. Mol. Mutagen. 52 (2011), 774–783.
10. [10] ICH, M7 Guideline, Assessment and Control of DNA Reactive (mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk, Step 4 Version, Dated 23 June 2014. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Step_4.pdf (accessed 18.02.16).
11. [11] Kimoto, T., et al. The PIGRET assay, a method for measuring Pig-a gene mutation in reticulocytes, is reliable as a short-term in vivo genotoxicity test: summary of the MMS/JEMS-collaborative study across 16 laboratoriesusing 24 chemicals. Mutat. Res. 811 (2016), 3–15.
12. [12] Dertinger, S.D., Phonethepswath, S., Avlasevich, S.L., Torous, D.K., Mereness, J., Bryce, S.M., Bemis, J.C., Bell, S., Weller, P., MacGregor, J.T., Efficient monitoring of in vivo Pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds. Toxicol. Sci. 130 (2012), 328–348.
13. [13] Kimoto, T., Horibata, K., Chikura, S., Hashimoto, K., Itoh, S., Sanada, H., Muto, S., Uno, Y., Yamada, M., Honma, M., Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat. Res. 755 (2013), 126–134.
14. [14] Hamada, S., Nakajima, K., Serikawa, T., Hayashi, M., The effect of aging on the results of the rat micronucleus assay. Mutagenesis 18 (2003), 273–275.
15. [15] Gold, L.S., The Carcinogenic Potency Database (CPDB). 2011 last updated: September 1 (accessed 17.04.13) http://toxnet.nlm.nih.gov/cpdb/.
16. [16] Kirkland, D., Aardema, M., Henderson, L., Müller, L., Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584 (2005), 1–256.
17. [17] Ashby, J., Beiji, B., Concomitant observation of UDS in the liver and micronuclei in the bone marrow of rats exposed to cyclophosphamide of 2- acetylaminofluorene. Mutat. Res. 150 (1985), 383–392.
18. [18] Heflich, R.H., Neft, R.E., Genetic toxicity of 2-acetylaminofluorene 2-aminofluorene, and some of their metabolites and model metabolites. Mutat. Res. 318 (1994), 73–174.
19. [19] Kishida, T., Muto, S.-I., Hayashi, M., Tsutsui, M., Tanaka, S., Murakami, M., Kuroda, J., Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague–Dawley and Wistar rats. J. Toxicol. Sci. 33:4 (2008), 447–457.
20. [20] Takashima, R., Takasawa, H., Kawasako, K., Ohyama, W., Okada, E., Narumi, K., Fujiishi, Y., Wako, Y., Yasunaga, K., Hattori, A., Kawabata, M., Nakadate, K., Nakagawa, M., Hamada, S., Evaluation of a repeated dose liver micronucleus assay in rats treated with two genotoxic hepatocarcinogens, dimethylnitrosamine and 2-acethylaminofluorene: the possibility of integrating micronucleus tests with multiple tissues into a repeated dose general toxicity study. Mutat. Res. 780–781:780 (2015), 18–24.
21. [21] Kraynak, A.R., Barnum, J.E., Cunningham, C.L., Ng, A., Ykoruk, B.A., Bennet, B., Stoffregen, D., Merschman, M., Freeland, E., Galloway, S.M., Alkaline comet assay in liver and stomach and micronucleus assay in bone marrow, from rats treated with 2-acetylaminofluorene, azidothymidine, cisplatin, or isobutyraldehyde. Mutat. Res. 786-788 (2015), 77–86.